An ultra-low-cost electroporator with microneedle electrodes (ePatch) for SARS-CoV-2 vaccination [Engineering]

Vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and other pathogens with pandemic potential requires safe, protective, inexpensive, and easily accessible vaccines that can be developed and manufactured rapidly at a large scale. DNA vaccines can achieve these criteria, but induction of strong immune responses has often required bulky,...
Source: Proceedings of the National Academy of Sciences - Category: Science Authors: Tags: Engineering, Immunology and Inflammation, Coronavirus (COVID-19) Biological Sciences Source Type: research